Envestnet Portfolio Solutions Inc. Has $4.11 Million Stake in Agilent Technologies, Inc. (NYSE:A)

Envestnet Portfolio Solutions Inc. lessened its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 11.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 30,606 shares of the medical research company's stock after selling 3,844 shares during the period. Envestnet Portfolio Solutions Inc.'s holdings in Agilent Technologies were worth $4,112,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of A. GSA Capital Partners LLP acquired a new stake in Agilent Technologies during the third quarter valued at approximately $499,000. Natixis Advisors LLC lifted its position in shares of Agilent Technologies by 15.7% during the 3rd quarter. Natixis Advisors LLC now owns 113,991 shares of the medical research company's stock valued at $16,926,000 after acquiring an additional 15,435 shares during the last quarter. Mutual of America Capital Management LLC boosted its stake in shares of Agilent Technologies by 0.3% during the 3rd quarter. Mutual of America Capital Management LLC now owns 50,306 shares of the medical research company's stock worth $7,469,000 after acquiring an additional 160 shares in the last quarter. Thrivent Financial for Lutherans grew its holdings in shares of Agilent Technologies by 3.1% in the 3rd quarter. Thrivent Financial for Lutherans now owns 292,789 shares of the medical research company's stock worth $43,473,000 after acquiring an additional 8,874 shares during the last quarter. Finally, Quest Partners LLC raised its position in shares of Agilent Technologies by 339.3% during the third quarter. Quest Partners LLC now owns 6,862 shares of the medical research company's stock worth $1,019,000 after purchasing an additional 5,300 shares during the period.

Remove Ads

Agilent Technologies Stock Up 0.4 %

NYSE:A traded up $0.44 during mid-day trading on Friday, reaching $120.72. The stock had a trading volume of 3,041,425 shares, compared to its average volume of 1,682,117. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66. The stock has a market cap of $34.42 billion, a P/E ratio of 27.75, a PEG ratio of 3.38 and a beta of 1.11. The business's 50 day moving average is $136.74 and its 200 day moving average is $137.30. Agilent Technologies, Inc. has a fifty-two week low of $117.17 and a fifty-two week high of $155.35.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. The business had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. As a group, sell-side analysts predict that Agilent Technologies, Inc. will post 5.57 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.82%. Agilent Technologies's dividend payout ratio (DPR) is presently 22.76%.

Wall Street Analyst Weigh In

A has been the subject of a number of recent analyst reports. Robert W. Baird decreased their price target on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating for the company in a research report on Thursday, February 27th. Citigroup raised their target price on shares of Agilent Technologies to $165.00 and gave the stock a "buy" rating in a report on Thursday, December 19th. StockNews.com upgraded shares of Agilent Technologies from a "hold" rating to a "buy" rating in a report on Tuesday, December 24th. Bank of America cut their target price on shares of Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating on the stock in a research note on Friday, December 13th. Finally, Sanford C. Bernstein lowered their price target on Agilent Technologies from $140.00 to $135.00 and set a "market perform" rating on the stock in a report on Tuesday, November 26th. Seven equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, Agilent Technologies currently has an average rating of "Moderate Buy" and an average price target of $146.15.

Insider Transactions at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the sale, the chief executive officer now directly owns 39,652 shares of the company's stock, valued at approximately $5,947,800. This represents a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Rodney Gonsalves sold 1,908 shares of the business's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the transaction, the vice president now directly owns 21,786 shares in the company, valued at $2,657,456.28. This trade represents a 8.05 % decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.